GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabis Bioscience International Holdings Inc (OTCPK:CBIH) » Definitions » Return-on-Tangible-Asset

CBIH (Cannabis Bioscience International Holdings) Return-on-Tangible-Asset : -790.12% (As of Nov. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Cannabis Bioscience International Holdings Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Cannabis Bioscience International Holdings's annualized Net Income for the quarter that ended in Nov. 2024 was $-0.32 Mil. Cannabis Bioscience International Holdings's average total tangible assets for the quarter that ended in Nov. 2024 was $0.04 Mil. Therefore, Cannabis Bioscience International Holdings's annualized Return-on-Tangible-Asset for the quarter that ended in Nov. 2024 was -790.12%.

The historical rank and industry rank for Cannabis Bioscience International Holdings's Return-on-Tangible-Asset or its related term are showing as below:

CBIH' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -1302   Med: -25.22   Max: 59.98
Current: -750

During the past 7 years, Cannabis Bioscience International Holdings's highest Return-on-Tangible-Asset was 59.98%. The lowest was -1302.00%. And the median was -25.22%.

CBIH's Return-on-Tangible-Asset is ranked worse than
98.64% of 1032 companies
in the Drug Manufacturers industry
Industry Median: 2.59 vs CBIH: -750.00

Cannabis Bioscience International Holdings Return-on-Tangible-Asset Historical Data

The historical data trend for Cannabis Bioscience International Holdings's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabis Bioscience International Holdings Return-on-Tangible-Asset Chart

Cannabis Bioscience International Holdings Annual Data
Trend Dec06 Dec07 May09 May10 May11 May23 May24
Return-on-Tangible-Asset
Get a 7-Day Free Trial 59.98 -25.22 12.69 -2.22 -1,302.00

Cannabis Bioscience International Holdings Quarterly Data
Aug09 Nov09 Feb10 May10 Aug10 Nov10 Feb11 May11 Aug11 Nov11 Feb12 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -486.27 -853.06 -720.53 -590.29 -790.12

Competitive Comparison of Cannabis Bioscience International Holdings's Return-on-Tangible-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Bioscience International Holdings's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannabis Bioscience International Holdings's Return-on-Tangible-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabis Bioscience International Holdings's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Cannabis Bioscience International Holdings's Return-on-Tangible-Asset falls into.


;
;

Cannabis Bioscience International Holdings Return-on-Tangible-Asset Calculation

Cannabis Bioscience International Holdings's annualized Return-on-Tangible-Asset for the fiscal year that ended in May. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: May. 2024 )  (A: May. 2023 )(A: May. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: May. 2024 )  (A: May. 2023 )(A: May. 2024 )
=-0.651/( (0.043+0.057)/ 2 )
=-0.651/0.05
=-1,302.00 %

Cannabis Bioscience International Holdings's annualized Return-on-Tangible-Asset for the quarter that ended in Nov. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Nov. 2024 )  (Q: Aug. 2024 )(Q: Nov. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Nov. 2024 )  (Q: Aug. 2024 )(Q: Nov. 2024 )
=-0.32/( (0.046+0.035)/ 2 )
=-0.32/0.0405
=-790.12 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Nov. 2024) net income data.


Cannabis Bioscience International Holdings  (OTCPK:CBIH) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Cannabis Bioscience International Holdings Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Cannabis Bioscience International Holdings's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannabis Bioscience International Holdings Business Description

Traded in Other Exchanges
N/A
Address
6201 Bonhomme Road, Suite 435N, Houston, TX, USA, 77036
Cannabis Bioscience International Holdings Inc provides educational systems focused on medical cannabis in cities throughout the United States and six countries in Latin America. The company provides services in therapeutic areas of clinical trials and services relating to sleep disorders through its sleep center in Houston, Texas. It offered concierge medicine at an affordable price through a membership-based model through its wholly-owned subsidiary.